Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T12:39:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma to the page content and included a new resource link to the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T20:27:35.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:03:45.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and an older notice (v3.4.1) was removed. These changes pertain to site maintenance and do not alter study details or eligibility information presented on the page.
    Difference
    0.3%
    Check dated 2026-02-11T05:56:24.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a site-wide funding notice about a lapse in government funding and updated to revision v3.4.1. The notice warns that site information may not be up to date and points to current operating status resources.
    Difference
    0.3%
    Check dated 2026-02-04T05:44:31.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    UI updates include showing the glossary, changing the QC-status label to 'Last Update Submitted that Met QC Criteria', correcting capitalization for 'No FEAR Act Data', and updating the revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:37.000Z thumbnail image

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.